News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
729,733 Results
Type
Article (44537)
Company Profile (292)
Press Release (684894)
Multimedia
Podcasts (82)
Webinars (17)
Section
Business (206145)
Career Advice (2048)
Deals (35698)
Drug Delivery (112)
Drug Development (82525)
Employer Resources (173)
FDA (16551)
Job Trends (15038)
News (349147)
Policy (32939)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2676)
Accelerated approval (32)
Adcomms (26)
Allergies (142)
Alliances (50323)
ALS (175)
Alzheimer's disease (1708)
Antibody-drug conjugate (ADC) (319)
Approvals (16800)
Artificial intelligence (516)
Autoimmune disease (155)
Automation (38)
Bankruptcy (362)
Best Places to Work (11715)
BIOSECURE Act (20)
Biosimilars (191)
Biotechnology (194)
Bladder cancer (159)
Brain cancer (58)
Breast cancer (642)
Cancer (4859)
Cardiovascular disease (411)
Career advice (1728)
Career pathing (35)
CAR-T (286)
CDC (44)
Celiac Disease (2)
Cell therapy (749)
Cervical cancer (36)
Clinical research (70222)
Collaboration (1722)
Company closure (4)
Compensation (1148)
Complete response letters (59)
COVID-19 (2819)
CRISPR (89)
C-suite (835)
Cystic fibrosis (147)
Data (6221)
Decentralized trials (2)
Denatured (26)
Depression (132)
Diabetes (501)
Diagnostics (6736)
Digital health (47)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (262)
Drug pricing (186)
Drug shortages (28)
Duchenne muscular dystrophy (232)
Earnings (90286)
Editorial (56)
Employer branding (21)
Employer resources (152)
Events (117950)
Executive appointments (970)
FDA (19657)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (11)
Frontotemporal dementia (23)
Funding (1476)
Gene editing (197)
Generative AI (43)
Gene therapy (607)
GLP-1 (980)
Government (4698)
Grass and pollen (7)
Guidances (383)
Healthcare (18979)
HIV (57)
Huntington's disease (45)
IgA nephropathy (86)
Immunology and inflammation (264)
Immuno-oncology (59)
Indications (105)
Infectious disease (3081)
Inflammatory bowel disease (190)
Inflation Reduction Act (14)
Influenza (113)
Intellectual property (248)
Interviews (317)
IPO (16691)
IRA (49)
Job creations (3661)
Job search strategy (1445)
JPM (58)
Kidney cancer (15)
Labor market (83)
Layoffs (552)
Leadership (31)
Legal (7984)
Liver cancer (95)
Longevity (14)
Lung cancer (660)
Lymphoma (377)
Machine learning (42)
Management (59)
Manufacturing (797)
MASH (165)
Medical device (13780)
Medtech (13833)
Mergers & acquisitions (20071)
Metabolic disorders (1275)
Multiple sclerosis (164)
NASH (18)
Neurodegenerative disease (326)
Neuropsychiatric disorders (87)
Neuroscience (2951)
Neurotech (1)
NextGen: Class of 2026 (6595)
Non-profit (4537)
Now hiring (65)
Obesity (600)
Opinion (270)
Ovarian cancer (166)
Pain (198)
Pancreatic cancer (225)
Parkinson's disease (285)
Partnered (33)
Patents (496)
Patient recruitment (483)
Peanut (56)
People (59172)
Pharmaceutical (63)
Pharmacy benefit managers (29)
Phase 1 (21959)
Phase 2 (30872)
Phase 3 (23021)
Pipeline (5202)
Policy (282)
Postmarket research (2589)
Preclinical (9437)
Press Release (69)
Prostate cancer (239)
Psychedelics (47)
Radiopharmaceuticals (283)
Rare diseases (860)
Real estate (5999)
Recruiting (70)
Regulatory (24650)
Reports (52)
Research institute (2471)
Resumes & cover letters (356)
Rett syndrome (27)
RNA editing (18)
RSV (76)
Schizophrenia (147)
Series A (240)
Series B (192)
Service/supplier (11)
Sickle cell disease (96)
Special edition (21)
Spinal muscular atrophy (165)
Sponsored (42)
Startups (3681)
State (2)
Stomach cancer (20)
Supply chain (104)
Tariffs (84)
The Weekly (54)
Vaccines (1032)
Venture capital (90)
Weight loss (387)
Women's health (89)
Worklife (18)
Date
Today (150)
Last 7 days (630)
Last 30 days (2226)
Last 365 days (30147)
2026 (3111)
2025 (30455)
2024 (35540)
2023 (40393)
2022 (51535)
2021 (56043)
2020 (54428)
2019 (46903)
2018 (35301)
2017 (32483)
2016 (31875)
2015 (37900)
2014 (31660)
2013 (26918)
2012 (29040)
2011 (29663)
2010 (27710)
Location
Africa (750)
Alabama (83)
Alaska (7)
Arizona (309)
Arkansas (13)
Asia (39859)
Australia (6563)
California (11267)
Canada (3269)
China (1099)
Colorado (475)
Connecticut (473)
Delaware (335)
Europe (86742)
Florida (1673)
Georgia (354)
Hawaii (3)
Idaho (62)
Illinois (857)
India (64)
Indiana (516)
Iowa (23)
Japan (426)
Kansas (125)
Kentucky (38)
Louisiana (27)
Maine (72)
Maryland (1379)
Massachusetts (8116)
Michigan (320)
Minnesota (628)
Mississippi (5)
Missouri (129)
Montana (32)
Nebraska (28)
Nevada (121)
New Hampshire (78)
New Jersey (2988)
New Mexico (30)
New York (2967)
North Carolina (1456)
North Dakota (10)
Northern California (5489)
Ohio (331)
Oklahoma (21)
Oregon (41)
Pennsylvania (2278)
Puerto Rico (23)
Rhode Island (47)
South America (1124)
South Carolina (65)
South Dakota (1)
Southern California (4380)
Tennessee (174)
Texas (1740)
United States (39962)
Utah (334)
Vermont (1)
Virginia (260)
Washington D.C. (81)
Washington State (923)
West Virginia (4)
Wisconsin (109)
Wyoming (2)
729,733 Results for "protein metrics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
PARTNERED WITH VIVA BIOTECH
Building the Next Generation of Biologics: Inside the Future of Protein Engineering
As bispecifics, ADCs, protein degraders, and AI-designed mini-proteins move into the clinic, discovery teams face a new bottleneck: engineering and producing molecules whose complexity challenges conventional workflows.
December 1, 2025
·
9 min read
·
BioSpace Insights
Press Releases
Beta Bionics Announces Preliminary, Unaudited Fourth Quarter 2025 Topline Financial Results and Key Metrics
January 9, 2026
·
6 min read
Press Releases
Origami Therapeutics Announces Global Collaboration with Ipsen to Advance Protein Degrader Program
February 2, 2026
·
2 min read
Press Releases
Talus Bio Announces New Collaboration with PRISM BioLab to Discover Novel Modulators of Transcription Factor and Protein-Protein Interaction Targets
December 18, 2025
·
4 min read
Press Releases
Galux Raises $29M Series B to Advance AI-Driven Protein Design for Drug Discovery
February 10, 2026
·
3 min read
Press Releases
HanchorBio and WuXi Biologics Enter Strategic Partnership to Advance Next-Generation Bi-and Multi-Functional Fusion Protein Pipeline
January 26, 2026
·
5 min read
Collaboration
Sanofi, Gilead Deepen Protein Degrader Pipelines in Separate Deals With Kymera
Gilead is betting up to $750 million on Kymera’s anti-CDK2 molecular glue for solid tumors, while Sanofi elected to move forward with another protein degrader from the biotech, designed to target immune-mediated diseases.
June 25, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Enodia Therapeutics Secures €20.7M to Advance a Small-Molecule Platform for Targeted Protein Degradation Enabled by Proteomics and Machine Learning
January 9, 2026
·
6 min read
Press Releases
Nomic Publishes Foundational Protein Quantification Technology in Nature Methods
November 10, 2025
·
3 min read
Press Releases
EpiBiologics Closes $107M Series B to Advance Pipeline of Novel Bispecific Antibodies to Selectively Degrade Extracellular Protein Targets in Oncology and Immunology
January 8, 2026
·
3 min read
1 of 72,974
Next
